STRS Ohio’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-10,900
| Closed | -$1.53M | – | 2151 |
|
|
2018
Q4 | $1.53M | Buy |
10,900
+100
| +0.9% | +$15.2K | 0.01% | 681 |
|
|
2018
Q3 | $1.84M | Buy |
10,800
+700
| +7% | +$118K | 0.01% | 667 |
|
|
2018
Q2 | $1.75M | Buy |
10,100
+8,300
| +461% | +$1.25M | 0.01% | 687 |
|
|
2018
Q1 | $207K | Buy |
1,800
+800
| +80% | +$85.1K | ﹤0.01% | 1487 |
|
|
2017
Q4 | $84K | Sell |
1,000
-1,500
| -60% | -$125K | ﹤0.01% | 1665 |
|
|
2017
Q3 | $230K | Hold |
2,500
| – | – | ﹤0.01% | 1517 |
|
|
2017
Q2 | $200K | Sell |
2,500
-26,283
| -91% | -$1.46M | ﹤0.01% | 1522 |
|
|
2017
Q1 | $1.21M | Sell |
28,783
-5,783
| -17% | -$238K | 0.01% | 752 |
|
|
2016
Q4 | $1.11M | Buy |
34,566
+21,477
| +164% | +$551K | ﹤0.01% | 799 |
|
|
2016
Q3 | $342K | Buy |
13,089
+1,889
| +17% | +$49.4K | ﹤0.01% | 1431 |
|
|
2016
Q2 | $259K | Buy |
11,200
+900
| +9% | +$22.4K | ﹤0.01% | 1496 |
|
|
2016
Q1 | $281K | Hold |
10,300
| – | – | ﹤0.01% | 1432 |
|
|
2015
Q4 | $293K | Buy |
+10,300
| New | +$276K | ﹤0.01% | 1431 |
|
|
2015
Q2 | – | Sell |
-1,200
| Closed | -$14K | – | 1995 |
|
|
2015
Q1 | $14K | Hold |
1,200
| – | – | ﹤0.01% | 1774 |
|
|
2014
Q4 | $14K | Hold |
1,200
| – | – | ﹤0.01% | 1701 |
|
|
2014
Q3 | $16K | Buy |
+1,200
| New | +$15.6K | ﹤0.01% | 1750 |
|
Other funds holding LOXO
STRS Ohio's LOXO Position: Q1 2019 in Review
STRS Ohio sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 10,900 shares — an estimated $1.53M sold.
STRS Ohio first reported a position in LOXO in Q3 2014 and held it in 16 quarters. The position peaked at $1.84M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- STRS Ohio reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- STRS Ohio sold 10,900 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.53M.
- STRS Ohio first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 16 quarters.
- STRS Ohio's Loxo Oncology, Inc position peaked at $1.84M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on STRS Ohio's 13F filing for Q1 2019, filed 19 Apr 2019.